Osteomalacia from Ifosfamide Chemotherapy in Young Adults
Author Information
Author(s): D. N. Church, Hassan A. B., Harper S. J., Wakeley C. J., Price C. G. A.
Primary Institution: Bristol Haematology and Oncology Centre
Hypothesis
Ifosfamide chemotherapy can lead to osteomalacia as a late metabolic complication in adults.
Conclusion
Osteomalacia can develop in adults after ifosfamide treatment, and clinicians should monitor for this complication.
Supporting Evidence
- Three cases of osteomalacia were reported in adults after ifosfamide treatment.
- Patients showed signs of renal tubular dysfunction and required monitoring.
- Clinicians should be aware of the potential for delayed complications from ifosfamide.
Takeaway
Ifosfamide, a cancer drug, can cause bone problems in adults even after treatment ends, so doctors need to watch for this.
Methodology
The study involved a literature review and case reports of three patients treated with ifosfamide.
Limitations
The study is based on a small number of cases and limited existing literature on adults.
Participant Demographics
Three adult patients with sarcoma treated with ifosfamide.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website